221 Digital assessment of stromal B cell aggregates as a biomarker of response to immune checkpoint inhibition in unresectable melanoma

Bibliographic Details
Main Authors: Katherine S Panageas, Yanyun Li, Margaret K Callahan, James W Smithy, Andrea P Moy, Ronglai Shen, Fiona Ehrich, Colleen Maher, Jasme Lee, Xiyu Peng, Nathaniel Aleynick, Mingqiang Zhuang, Travis Hollmann
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:Journal for ImmunoTherapy of Cancer
_version_ 1827576978089181184
author Katherine S Panageas
Yanyun Li
Margaret K Callahan
James W Smithy
Andrea P Moy
Ronglai Shen
Fiona Ehrich
Colleen Maher
Jasme Lee
Xiyu Peng
Nathaniel Aleynick
Mingqiang Zhuang
Travis Hollmann
author_facet Katherine S Panageas
Yanyun Li
Margaret K Callahan
James W Smithy
Andrea P Moy
Ronglai Shen
Fiona Ehrich
Colleen Maher
Jasme Lee
Xiyu Peng
Nathaniel Aleynick
Mingqiang Zhuang
Travis Hollmann
author_sort Katherine S Panageas
collection DOAJ
first_indexed 2024-03-08T21:20:13Z
format Article
id doaj.art-488d9b895cec4f1d8023e432e9de0675
institution Directory Open Access Journal
issn 2051-1426
language English
last_indexed 2024-03-08T21:20:13Z
publishDate 2023-11-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj.art-488d9b895cec4f1d8023e432e9de06752023-12-21T11:20:09ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.0221221 Digital assessment of stromal B cell aggregates as a biomarker of response to immune checkpoint inhibition in unresectable melanomaKatherine S Panageas0Yanyun Li1Margaret K Callahan2James W Smithy3Andrea P Moy4Ronglai Shen5Fiona Ehrich6Colleen Maher7Jasme Lee8Xiyu Peng9Nathaniel Aleynick10Mingqiang Zhuang11Travis Hollmann124Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, USAMemorial Sloan-Kettering Cancer Center, New York, NY, USAMemorial Sloan-Kettering Cancer Center, New York, NY, USAMemorial Sloan-Kettering Cancer Center, New York, NY, USAMemorial Sloan-Kettering Cancer Center, New York, NY, USAMemorial Sloan-Kettering Cancer Center, New York, NY, USAMemorial Sloan-Kettering Cancer Center, New York, NY, USAMemorial Sloan-Kettering Cancer Center, New York, NY, USAMemorial Sloan-Kettering Cancer Center, New York, NY, USAMemorial Sloan-Kettering Cancer Center, New York, NY, USAMemorial Sloan-Kettering Cancer Center, New York, NY, USAMemorial Sloan-Kettering Cancer Center, New York, NY, USAMemorial Sloan-Kettering Cancer Center, New York, NY, USA
spellingShingle Katherine S Panageas
Yanyun Li
Margaret K Callahan
James W Smithy
Andrea P Moy
Ronglai Shen
Fiona Ehrich
Colleen Maher
Jasme Lee
Xiyu Peng
Nathaniel Aleynick
Mingqiang Zhuang
Travis Hollmann
221 Digital assessment of stromal B cell aggregates as a biomarker of response to immune checkpoint inhibition in unresectable melanoma
Journal for ImmunoTherapy of Cancer
title 221 Digital assessment of stromal B cell aggregates as a biomarker of response to immune checkpoint inhibition in unresectable melanoma
title_full 221 Digital assessment of stromal B cell aggregates as a biomarker of response to immune checkpoint inhibition in unresectable melanoma
title_fullStr 221 Digital assessment of stromal B cell aggregates as a biomarker of response to immune checkpoint inhibition in unresectable melanoma
title_full_unstemmed 221 Digital assessment of stromal B cell aggregates as a biomarker of response to immune checkpoint inhibition in unresectable melanoma
title_short 221 Digital assessment of stromal B cell aggregates as a biomarker of response to immune checkpoint inhibition in unresectable melanoma
title_sort 221 digital assessment of stromal b cell aggregates as a biomarker of response to immune checkpoint inhibition in unresectable melanoma
work_keys_str_mv AT katherinespanageas 221digitalassessmentofstromalbcellaggregatesasabiomarkerofresponsetoimmunecheckpointinhibitioninunresectablemelanoma
AT yanyunli 221digitalassessmentofstromalbcellaggregatesasabiomarkerofresponsetoimmunecheckpointinhibitioninunresectablemelanoma
AT margaretkcallahan 221digitalassessmentofstromalbcellaggregatesasabiomarkerofresponsetoimmunecheckpointinhibitioninunresectablemelanoma
AT jameswsmithy 221digitalassessmentofstromalbcellaggregatesasabiomarkerofresponsetoimmunecheckpointinhibitioninunresectablemelanoma
AT andreapmoy 221digitalassessmentofstromalbcellaggregatesasabiomarkerofresponsetoimmunecheckpointinhibitioninunresectablemelanoma
AT ronglaishen 221digitalassessmentofstromalbcellaggregatesasabiomarkerofresponsetoimmunecheckpointinhibitioninunresectablemelanoma
AT fionaehrich 221digitalassessmentofstromalbcellaggregatesasabiomarkerofresponsetoimmunecheckpointinhibitioninunresectablemelanoma
AT colleenmaher 221digitalassessmentofstromalbcellaggregatesasabiomarkerofresponsetoimmunecheckpointinhibitioninunresectablemelanoma
AT jasmelee 221digitalassessmentofstromalbcellaggregatesasabiomarkerofresponsetoimmunecheckpointinhibitioninunresectablemelanoma
AT xiyupeng 221digitalassessmentofstromalbcellaggregatesasabiomarkerofresponsetoimmunecheckpointinhibitioninunresectablemelanoma
AT nathanielaleynick 221digitalassessmentofstromalbcellaggregatesasabiomarkerofresponsetoimmunecheckpointinhibitioninunresectablemelanoma
AT mingqiangzhuang 221digitalassessmentofstromalbcellaggregatesasabiomarkerofresponsetoimmunecheckpointinhibitioninunresectablemelanoma
AT travishollmann 221digitalassessmentofstromalbcellaggregatesasabiomarkerofresponsetoimmunecheckpointinhibitioninunresectablemelanoma